Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Quanta Therapeutics has raised $50.7M in total funding. The most recent round was Series D. The last funding was announced in October 2026.
Quanta Therapeutics's investors include AbbVie, Avidity Partners, Vida Ventures, Sofinnova Investments, Longitude Capital.
Quanta Therapeutics is headquartered in San Francisco, United States.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Quanta Therapeutics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quanta Therapeutics — Funding & Investors." VCBacked, October 24, 2026, https://www.vcbacked.co/company/quanta-therapeutics. Accessed November 16, 2026.
VCBacked. (2026). Quanta Therapeutics — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/quanta-therapeutics
{{cite web |title=Quanta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quanta-therapeutics |website=VCBacked |access-date=November 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Quanta Therapeutics? Request a listing update